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Abstract
We evaluated the relationship of leptin with hypertension adjusted for
body mass index (BMI) and/or waist circumference in a population of
Japanese-Brazilian women aged ≥30 years with centrally distributed
adiposity. After excluding diabetic subjects, the study subjects - who
participated in a population-based study on the prevalence of meta-
bolic syndrome - showed prevalence rates of obesity (BMI ≥25 kg/m2)
and central adiposity (waist ≥80 cm) of 32.0 and 37.8%, respectively.
The hypertensive group (N = 162) was older, had higher BMI (24.9 ±
4.2 vs 23.3 ± 3.4 kg/m2, P < 0.001), waist circumference (81.1 ± 10.1
vs 76.3 ± 8.2 cm, P < 0.001) and insulin levels (8.0 ± 6.2 vs 7.1 ± 4.9
µU/mL, P < 0.05) than the normotensive group (N = 322) and showed
an unfavorable metabolic profile (higher 2-h plasma glucose, C-
reactive protein and non-HDL cholesterol levels). Leptin did not differ
between groups (8.2 ± 6.8 vs 7.2 ± 6.6 ng/mL, P = 0.09, for hyperten-
sive vs normotensive, respectively) and its levels correlated signifi-
cantly with anthropometric variables but not with blood pressure.
Logistic regression analysis indicated that age and waist were inde-
pendently associated with hypertension but not with homeostasis
model assessment of insulin resistance or leptin levels. The lack of an
independent association of hypertension with metabolic parameters
(2-h glucose, C-reactive protein and non-HDL cholesterol) after ad-
justment for central adiposity suggested that visceral fat deposition
may be the common mediator of the disturbances of the metabolic
syndrome. Our data indicate that age and waist are major determinants
of hypertension in this population of centrally obese (waist ≥80 cm)
Japanese-Brazilian women, but do not support a role for leptin in the
elevation of blood pressure.
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Introduction
Several metabolic disturbances found in
conditions of excessive adiposity are associ-
ated with hypertension. A close relationship
between body adiposity and insulin and leptin
levels has been reported (1) but it is not
known whether or not the latter contributes
independently to elevation of blood pres-
sure. Schutte et al. (2) found that leptin was
directly associated with blood pressure and
negatively associated with arterial compli-
ance in obese African women with hyper-
tension. In addition to the action of this
adipocyte-derived hormone on satiety through
hypothalamic receptors, leptin seems to in-
crease sympathetic nervous system (SNS)
activity (3). Based on the importance of
sympathetic tone in the pathophysiology of
hypertension, a role for leptin has been sug-
gested as the link between obesity and hy-
pertension (4).
Data obtained in obese hyperleptinemic
agouti yellow mice have indicated selective
resistance to the action of leptin on the hypo-
thalamus; the maintenance of SNS hyperac-
tivity in these animals could explain blood
pressure elevation (5). Similarly, the hyper-
leptinemia found in human obesity also sug-
gests a leptin resistance state (6), but it is an
intriguing fact that leptin is more closely
related to peripheral fat mass (subcutane-
ous) while hypertension-related metabolic
disturbances are mainly associated with vis-
ceral fat.
Literature data are controversial since
some studies have found no correlation be-
tween leptinemia and hypertension (7) and
others have found a positive association be-
tween hypertension and leptinemia in
women, but all of them included obese sub-
jects (2,8,9). An epidemiological study on
the prevalence of diabetes and associated
diseases in Japanese-Brazilians showed that
such a population is at high risk for the
metabolic syndrome including hypertension.
Interestingly, their body mass index (BMI)
is not compatible with obesity according to
the values proposed by the WHO for Cauca-
sians, despite showing centrally distributed
adiposity (10). Therefore, Japanese-Brazil-
ians constitute an interesting model that could
permit an independent analysis of the effects
of central fat on the development of meta-
bolic syndrome. It would be interesting to
determine whether visceral fat is more rel-
evant than subcutaneous fat to the elevation
of blood pressure and metabolic disturbances.
The present study assessed the relation-
ships of hormonal variables with hyperten-
sion in Japanese-Brazilian women, adjusted
for BMI or waist circumference. Specifical-
ly, independent associations of insulin and
leptin levels with elevated blood pressure
were investigated.
Patients and Methods
Study population
A survey conducted on a Japanese-Bra-
zilian population living in Bauru, SP, Brazil,
was designed to estimate the prevalence of
diabetes and associated diseases (11). The
entire population over 30 years of age (N =
1,751) was invited to participate. Clinical
and laboratory data from 1,330 first- (born in
Japan) and second-generation (born in Bra-
zil) subjects were collected. Among 717
women, 233 had diabetes.
The study was approved by the Ethics
Committee of the Universidade Federal de
São Paulo. After giving written informed
consent, participants were interviewed at
home using standardized questionnaires and
scheduled for clinical and laboratory proce-
dures after an overnight fast.
Protocol
BMI was calculated as weight (kilograms)
divided by height (meters) squared and waist
circumference was measured at the umbili-
cus. Instead of a BMI cutoff of 30 kg/m2 (12)
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to define obesity, the value of 25.0 kg/m2
was employed in the present study, as previ-
ously proposed for Japanese populations (13).
Women with a waist circumference ≥80 cm
were characterized as centrally obese (13).
Bioelectrical impedance was used to assess
body composition and fat mass was expressed
as percentage. Blood pressure was measured
three times after a 10-min rest in the sitting
position with an automatic device (Omron
model HEM-712C, Omron Health Care, Inc.,
Vernon Hills, IL, USA). Hypertension was
defined as systolic or diastolic blood pres-
sure ≥140/90 mmHg or the use of antihyper-
tensive medications (14). Blood samples
were obtained twice, i.e., under fasting con-
ditions and 2 h after the ingestion of 75 g
glucose. The glucose load was administered
to non-diabetic subjects and to those with
self-reported diabetes mellitus but fasting
capillary glucose <11.1 mmol/L, screened
by the use of glucose-oxidase strips. Glu-
cose tolerance status was based on 1999
WHO criteria (15) or use of antidiabetic
agents. Considering the heterogeneity of ß
cell secretory capacity and circulating insu-
lin levels, diabetic subjects (fasting plasma
glucose ≥7 mmol/L or 2-h level ≥11.1 mmol/
L) were excluded from the analysis, which
was carried out on 484 nondiabetic women.
Plasma glucose and uric acid were deter-
mined by routine methods. Cholesterol con-
tents of lipoprotein fractions and triglyceri-
des were measured enzymatically and pro-
cessed with an automatic analyzer. C-reac-
tive protein was determined by a chemilumi-
nescent immunometric assay (normal range:
0.05-0.11 mg/dL). Sera were stored at -20°C
for hormonal determinations. Insulin was
determined by a monoclonal antibody-based
immunofluorimetric assay (AutoDelfia, Per-
kin-Elmer Life Sciences Inc., Norton, OH,
USA) and leptin by radioimmunoassay
(Linco Research Inc., St. Charles, MO, USA).
Insulin sensitivity was assessed by the ho-
meostasis model assessment of insulin resis-
tance (HOMA-IR) according to Matthews
et al. (16).
Statistical analysis was performed using
the Stata 7.0 software package (Stata Corpo-
ration, College Station, TX, USA). Data from
the normo- and hypertensive groups were
compared by the unpaired Student t-test or
Wilcoxon test according to Levene’s test for
equality of variances. Data are reported as
means ± SD or median and range. Preva-
lence rates were estimated by point and 95%
confidence interval (95% CI). The chi-square
test was used to compare frequencies. Pear-
son coefficient was used to test the correla-
tion of blood pressure and leptin with demo-
graphic, clinical and laboratory parameters.
Backward models of logistic regression were
created including hypertension as the de-
pendent variable and leptin as the main ex-
posure of interest, adjusted for a number of
other variables (age, waist, BMI, fat mass,
fasting and 2-h glucose, 2-h insulin, HOMA-
IR, uric acid, C-reactive protein, serum creati-
nine, and lipid profile). The level of signifi-
cance was set at P < 0.05 in all analyses.
Results
Among the 484 nondiabetic Japanese-
Brazilian women studied, contrasting preva-
lence rates of obesity were observed when
different diagnostic criteria were used. Us-
ing WHO criteria (12), 5.6% obese subjects
were found. However, this rate increased to
32.0% when specific criteria for Asians (13)
were applied. Also, a high 37.8% prevalence
of central adiposity was observed.
Patients were stratified according to the
presence of hypertension, whose prevalence
rate was 33% (95% CI: 29-38%). As ex-
pected, the women in the hypertensive group
(N = 162) were older and showed an unfa-
vorable metabolic profile and higher BMI
than the normotensive group (Table 1). Mean
insulin levels were higher in hypertensive
than in normotensive subjects (8.0 ± 6.2 vs
7.1 ± 4.9 µU/mL, P < 0.05) but the difference
in leptin levels was not statistically signifi-
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logistic regression analysis is depicted in
Table 3. Fasting insulin and plasma glucose
or HOMA-IR alternatively entered the mod-
els; the same procedure was adopted for
BMI or waist circumference, providing simi-
lar results (data not shown). Age, waist and
uric acid were independently associated with
hypertension after adjusting for 2-h glucose,
C-reactive protein and non-HDL cholesterol.
A borderline significance was detected for
the association of hypertension with triglyc-
erides (P = 0.07), but not with leptin or
HOMA-IR.
Discussion
Hypertension - as a component of the
metabolic syndrome - results from complex
and multifactorial mechanisms including
obesity-induced metabolic and hormonal
disturbances. Among these mechanisms,
adipose tissue-derived molecules have di-
rect (non-esterified fatty acids, angiotensin
II, nitric oxide, prostacyclin) or indirect
(leptin) effects on the regulation of SNS
activity, sodium reabsorption and renin-an-
giotensin-aldosterone system activity (17).
The association of hypertension with hyper-
insulinemia was documented in some (18)
but not all studies (19). Controversies also
exist regarding an association between hy-
pertension and leptin levels (20-27).
An association between hyperleptinemia
and hypertension has been found in obese
subjects at risk for metabolic syndrome
(2,8,27-29). Most studies regarding the in-
volvement of hormonal factors in the gene-
sis of hypertension include obese subjects.
Japanese-Brazilians offer an opportunity to
more specifically investigate the importance
of body fat distribution for blood pressure
elevation, since they constitute a population
with localized central adiposity without over-
all obesity and a high prevalence of meta-
bolic syndrome (9). The mean BMI of this
population would not be considered elevated
according to WHO criteria. However, using
Table 1. Main characteristics of nondiabetic Japanese-Brazilians according to the
presence of hypertension.
Normotensive (N = 322) Hypertensive (N = 162)
Age (years) 52 ± 12 61 ± 11*
Systolic BP (mmHg) 114 ± 14.0 151 ± 20.6*
Diastolic BP (mmHg) 69 ± 8.5 86 ± 12.3*
BMI (kg/m2) 23.3 ± 3.4 24.9 ± 4.2*
Waist circumference (cm) 76.3 ± 8.2 81.1 ± 10.1*
Fat mass (%) 28 ± 6 29 ± 6*
Fasting glucose (mmol/L) 5.9 ± 0.5 6.0 ± 0.5*
2-h glucose (mmol/L) 7.1 ± 1.5 7.6 ± 1.4*
Total cholesterol (mmol/L) 5.3 ± 1.2 6.7 ± 1.1*
HDL-cholesterol (mmol/L) 1.3 ± 0.3 1.4 ± 0.2
LDL-cholesterol (mmol/L) 3.3 ± 0.9 3.6 ± 0.9*
Triglyceride (mmol/L) 1.6 ± 1.1 2.1 ± 1.4*
Uric acid (mmol/L) 0.291 ± 0.101 0.327 ± 0.071*
C-reactive protein (mg/dL) 0.200 ± 0.57 0.250 ± 0.29
Fasting insulin (µU/mL) 7.1 ± 4.9 8.0 ± 6.2
2-h insulin (µU/mL) 52.6 ± 45.4 67.9 ± 55.9*
HOMA-IR 1.9 ± 1.3 2.2 ± 1.8
Leptin (ng/mL) 7.2 ± 6.6 8.2 ± 6.8
Data are reported as mean ± SD. Reference values: total cholesterol - desirable: <5.2
mmol/L; borderline: 5.2-6.1 mmol/L; high risk: >6.2 mmol/L. HDL-c: 0.88-2.28 mmol/L.
LDL-c: <3.37 mmol/L. Triglyceride: <1.65 g/L. Fasting insulin: 6-35 µU/mL. Leptin
(women with BMI 18-25 kg/m2): 7.4 ± 3.7 ng/mL. BP = blood pressure; BMI = body
mass index; HOMA-IR = homeostasis model assessment of insulin resistance.
*P < 0.05 compared to normotensive subjects (Student t-test or Wilcoxon test accord-
ing to Levene’s test for equality of variances).
cant (8.2 ± 6.8 vs 7.2 ± 6.6 ng/mL, P =
0.092).
Blood pressure correlated significantly
with anthropometric parameters and also with
insulin levels despite a low correlation coef-
ficient (Table 2). On the other hand, no
correlation was detected between blood pres-
sure and leptin levels. The final model of
Table 2. Correlation coefficients between variables of main interest.
Mean BP BMI Waist Fat mass 2-h insulin Leptin HOMA-IR
Mean BP 1.00
BMI 0.24* 1.00
Waist 0.29* 0.84* 1.00
Fat mass 0.18* 0.79* 0.71* 1.00
2-h insulin 0.09* 0.30* 0.30* 0.23* 1.00
Leptin 0.01 0.14* 0.14* 0.11* 0.15* 1.00
HOMA-IR 0.10* 0.32* 0.31* 0.23* 0.99* 0.09 1.00
*P<0.05, correlation coefficients by the Pearson method. BP = blood pressure; BMI =
body mass index; HOMA-IR = homeostasis model assessment of insulin resistance.
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specific criteria for Asians (13), high preva-
lence rates of obesity and central adiposity
were observed. A stronger correlation with
waist than with fat mass may indicate the
importance of the visceral component for
the BMI. Our finding of low leptin levels
was expected considering their BMI and fat
mass which, together with gender, explain
81% of leptin variance in humans (30).
Studies in animals and humans have sug-
gested a link between leptin and hyperten-
sion by activation of the SNS and an in-
crease of sodium reabsorption (2,3). Hyper-
leptinemia was found in obese rats with
increased blood pressure (20) and hormone
administration induced sympathetic hyper-
activity (21,22). These data were in agree-
ment with a predominant pressor action in-
duced by peripheral or central infusion of
leptin (23,24) but not with the finding of
increased endothelial nitric oxide in isolated
blood vessels (25) or the results of acute
infusion which suggested a depressor action
(26).
Leptin - mainly secreted by the subcuta-
neous adipose tissue - was used to indirectly
investigate the possible influence of total fat
on blood pressure in the present study. The
lack of association of this hormone with
hypertension in logistic regression did not
support a role for blood pressure elevation,
which should be investigated in a longitudi-
nal study.
In this context, some studies have not
found an independent association of leptin
with blood pressure when adjusted for gen-
eral obesity. El-Gharbawy et al. (31) found a
correlation between leptin and blood pres-
sure in African women with hypertension
and obesity, which disappeared after adjust-
ments for other components of the insulin
resistance syndrome. In a similar popula-
tion, Schutte et al. (2) found that leptin was
positively associated with systolic blood pres-
sure in obese but not in lean women. These
findings agree with others, which showed
that angiotensin II and leptin levels were
strong predictors of blood pressure in obese
women, but not in lean women in whom
only the former predicted blood pressure
(32). Also, in a Chinese population, Hu et al.
(33) observed that a significant association
between leptin and blood pressure disap-
peared after adjusting for BMI, whereas the
association between BMI and blood pres-
sure persisted after adjusting for leptin levels.
Considering the effect of hyperinsuline-
mia in increasing the expression of the ob
gene in adipocytes (34), it is probable that
previously reported associations of leptin
with blood pressure were due to the influ-
ence of concomitant elevation of insulin lev-
els in obese subjects. In fact, we confirmed
this significant correlation between these
hormone levels, in agreement with other
studies conducted in non-diabetic subjects
(35) and in Japanese diabetic subjects with
normal BMI (34).
Our final logistic regression model showed
that waist circumference - indicative of vis-
ceral fat deposition - was independently as-
sociated with hypertension. This is in agree-
ment with the reported differences in the
prevalence of hypertension according to body
fat distribution (36). Prospective studies in-
dicated that visceral fat was implicated in
metabolic and hemodynamic abnormalities
(35) linked to insulin resistance. Activation
of the SNS may be one of the mechanisms
underlying such abnormalities. In the pres-
ent study, weak correlation coefficients for
Table 3. Final model of logistic regression (hypertension as the dependent variable).
OR P 95% CI
Age 1.011 0.000 1.008 1.015
Waist 1.007 0.028 1.001 1.011
Uric acid 1.043 0.038 1.002 1.084
Triglyceride 1.000 0.077 1.000 1.001
HOMA-IR 1.010 0.507 -1.020 1.041
Leptin -1.002 0.648 -1.008 1.005
Adjusted for 2-h glucose, C-reactive protein and non-HDL cholesterol (nonsignificant).
HOMA-IR = homeostasis model assessment of insulin resistance; OR = odds ratio;
95% CI = 95% confidence interval.
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blood pressure with 2-h insulin and HOMA-
IR were found but not confirmed in multi-
variate analysis. Adjustments for age and
waist may have weakened such association.
In fact, Rocchini et al. (19) suggested that
SNS activation is important in the pathogen-
esis of obesity hypertension, whereas insu-
lin resistance associated with obesity might
be mediated in part by alterations in the
central or peripheral α-adrenergic receptors,
and concluded that obesity-induced hyper-
tension and obesity-induced insulin resis-
tance are not directly related (19). In addi-
tion, it is known that a simultaneous impair-
ment of vascular resistance and arterial com-
pliance is associated with aging in different
patterns of hypertension (37).
Our data support the hypothesis that cen-
tral distribution of fat should be a determi-
nant of hypertension. In the presence of
increased central adiposity, concomitant with
low total adiposity, typical associations of
metabolic parameters with hypertension are
minimized. A role of leptin in blood pressure
elevation in this specific population of Japa-
nese-Brazilian women was not suggested, in
agreement with the hypothesis that visceral
fat-related factors should be more relevant
than subcutaneous fat in the association with
hypertension.
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